Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

More On PVA.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates
  • Research Reports

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

pSivida Corp. (PVA.AX)

-ASX
4.02 Up 0.02(0.50%) Apr 16, 8:12PM EDT
Get the big picture on all your investments.
Prev Close:4.00
Open:4.02
Bid:3.50
Ask:4.02
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:4.02 - 4.02
52wk Range:2.00 - 5.64
Volume:285
Avg Vol (3m):2,028
Market Cap:109.97M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Reports

  • No Reports available for PVA.AX at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):49.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

pSivida Corp. develops products to deliver drugs and biologics primarily in the United States and the United Kingdom. The company, through its Durasert and BioSilicon technology platforms, focuses on the treatment of chronic diseases of the back o... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback